A Pregenomic RNA Sequence Adjacent to DR1 and Complementary to Epsilon Influences Hepatitis B Virus Replication Efficiency  by Tang, Hong & McLachlan, Alan
Virology 303, 199–210 (2002)A Pregenomic RNA Sequence Adjacent to DR1 and Complementary to Epsilon Influences
Hepatitis B Virus Replication Efficiency1
Hong Tang*,† and Alan McLachlan*,2
*Department of Cell Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California;
and †Viral Hepatitis Research Unit, West China Hospital, West China Medical School, Sichuan University,
Guo Xue Xiang, No. 37, Chengdu, Sichuan 610041, People’s Republic of China
Received April 18, 2002; returned to author for revision June 7, 2002; accepted July 1, 2002
Hepatitis B virus (HBV) possesses a 3.2-kb partially double-stranded DNA genome that is generated inside the nucleo-
capsid by the reverse transcription of the 3.5-kb pregenomic viral transcript. The initial steps in viral replication involve the
recognition of an encapsidation signal termed epsilon () at the 5-end of the pregenomic RNA by the HBV polymerase. The
polymerase-bound pregenomic RNA is subsequently incorporated into an immature nucleocapsid particle and minus-strand
HBV DNA synthesis is initiated utilizing the bulge region of  as a template and a tyrosine residue in the amino-terminal region
of the polymerase as a primer. Three nucleotides complementary to the 3-end of the bulge region of  are synthesized and
subsequently translocated with the polymerase molecule to the acceptor site located in the DR1 sequence present at the
3-end of the pregenomic RNA. Using mutagenesis analysis, a sequence element designated phi () located upstream of the
3 DR1 sequence has been identified that is complementary to  and is important for efficient viral replication. This element
may bring the 3 DR1 sequence into proximity with the three nucleotide primer synthesized at the bulge of  and facilitate
primer translocation to the 3 DR1 acceptor sequence. Sequence elements with similar proximity to the 3 DR1 sequences
and complementarity to  are present in the woodchuck hepatitis virus (WHV) and duck hepatitis B virus (DHBV), suggestingINTRODUCTION
The hepatitis B virus (HBV) is a 42-nm particle com-
prising an enveloped 28-nm nucleocapsid that contains
the partially double-stranded 3.2-kb DNA genome (Ga-
nem and Varmus, 1987; McLachlan, 1991). The HBV
genomic DNA in the virion is synthesized in the nucleo-
capsid by the reverse transcription of a greater-than-
genome length pregenomic 3.5-kb RNA (Will et al., 1987;
McLachlan, 1991). This process of viral replication is
unique to the hepadnaviruses and involves several par-
tially defined steps. Transcription of covalently closed
circular HBV DNA from the nucleocapsid promoter pro-
ceeds through the polyadenylation signal sequence on
the initial passage of the cellular RNA polymerase
around the viral genome generating the 3.5-kb pre-
genomic RNA (Cattaneo et al., 1984; Yokosuka et al.,
1986; Imazeki et al., 1987; Su et al., 1989; Russnak and
Ganem, 1990). The 3.5-kb pregenomic RNA is translated
to produce the core and polymerase polypeptides (Will et
al., 1987; Ou et al., 1990). The HBV polymerase binds to
a stem-loop structure designated epsilon () at the 5-
end of the pregenomic RNA (Junker-Niepmann et al.,
1 Publication number 14772-CB from The Scripps Research Institute.1991990; Knaus and Nassal, 1993; Pollack and Ganem, 1994;
Wang et al., 1994). The pregenomic RNA–HBV polymer-
ase complex is subsequently incorporated into the viral
nucleocapsid that is composed of core polypeptide sub-
units (Hirsch et al., 1990; Bartenschlager et al., 1990;
Bartenschlager and Schaller, 1992; Pollack and Ganem,
1993, 1994; Fallows and Goff, 1995). The polymerase
subsequently synthesizes the first three nucleotides of
the HBV minus-strand DNA using a tyrosine residue in
the amino-terminal region of the polymerase molecule as
a primer and the bulge region of  as a template (Gerlich
and Robinson, 1980; Wang and Seeger, 1992, 1993; Zou-
lim and Seeger, 1994; Weber et al., 1994; Tavis et al.,
1994; Lanford et al., 1995, 1997; Nassal and Rieger, 1996;
Jiang and Loeb, 1997). The polymerase and the co-
valently attached three nucleotides are translocated from
 at the 5-end of the pregenomic RNA to a complemen-
tary sequence present in the DR1 element located at the
3-end of the pregenomic RNA (Seeger and Maragos,
1991; Tavis et al., 1994; Tavis and Ganem, 1995; Loeb and
Tian, 1995; Nassal and Rieger, 1996). The regulation of
this translocation step is poorly understood but it clearly
requires more than the simple complementarity between
the donor sequence in the  bulge and the acceptor
sequence in the DR1 element (Tavis et al., 1994; Tavisthe  regulatory element may be phylogenetically conserve
DNA synthesis. © 2002 Elsevier Science (USA)
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doi:10.1006/viro.2002.1645to its functional importance in hepadnavirus minus-strand
and Ganem, 1995; Loeb and Tian, 1995; Nassal and
Rieger, 1996). It has been suggested that the pregenomic
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RNA may assume a conformation that brings these se-
quences into close proximity so that the translocation
step can be readily achieved (Wang and Seeger, 1993;
Tavis and Ganem, 1995; Loeb and Tian, 1995; Nassal and
Rieger, 1996). Alterations in the conformation of  and the
polymerase molecule might also be associated with this
process (Tavis and Ganem, 1996; Tavis et al., 1998; Beck
and Nassal, 1998). After the polymerase translocates to
the DR1 sequence at the 3-end of the pregenomic RNA,
minus-strand synthesis can proceed by reverse tran-
scription of the pregenomic RNA (Wang and Seeger,
1993).
The RNase H activity associated with the HBV poly-
merase degrades the pregenomic RNA as the minus-
strand DNA is synthesized (Radziwill et al., 1990). At the
completion of the minus-strand synthesis, an oligoribo-
nucleotide approximately 17 bases in length from the
5-end of the pregenomic RNA possessing the DR1 se-
quence is not degraded by the RNase H activity (Lien et
al., 1986; Will et al., 1987; Loeb et al., 1991). This oligori-
bonucleotide is translocated to the DR2 sequence on the
HBV minus-strand and serves as the primer for plus-
strand synthesis (Will et al., 1987; Seeger et al., 1986;
Staprans et al., 1991; Loeb et al., 1996; Seeger and
Maragos, 1989). To generate the partially double-
stranded HBV genome present in the virion, plus-strand
synthesis from DR2 to the 5-end of the minus-strand
occurs. The 3-end of the plus-strand is subsequently
translocated to the 3-end of the minus-strand utilizing
the eight nucleotide terminal redundancy present in the
minus-strand DNA (Will et al., 1987; Loeb et al., 1997; Lien
et al., 1987). The plus-strand is then extended by the HBV
polymerase to produce the 3.2-kb partially double-
stranded DNA found in the mature virion (Havert and
Loeb, 1997).
In this study, a sequence element designated phi ()
has been identified that is important for efficient viral
replication. This 19 nucleotide sequence is located 32
nucleotides upstream of the DR1 element and is com-
plementary to . Consequently, it appears most likely that
this sequence element enhances viral replication effi-
ciency by juxtaposing the HBV polymerase with the co-
valently attached three nucleotides located at the bulge
region of  with the DR1 sequence present at the 3-end
of the pregenomic RNA. By generating an alternative
RNA secondary structure element between  and  se-
quences, the  sequence could enhance the efficiency
of the initial translocation step that is necessary for the
elongation step in minus-strand DNA synthesis. The ob-
servation that similar secondary structures can form be-
tween  and  sequences in woodchuck hepatitis virus
(WHV) and duck hepatitis B virus (DHBV) pregenomic
RNA further supports the suggestion that the  se-
quence is an important element involved in mediating
this translocation step in the hepadnavirus replication
cycle.
RESULTS AND DISCUSSION
Identification of a pregenomic RNA sequence
adjacent to DR1 that is important for efficient
HBV replication
The HBV polymerase binds to a stem-loop struc-
ture designated  at the 5-end of the pregenomic RNA
(Junker-Niepmann et al., 1990; Knaus and Nassal, 1993;
Pollack and Ganem, 1994; Wang et al., 1994). The pre-
genomic RNA–HBV polymerase complex is encapsi-
dated and viral DNA synthesis proceeds inside the nu-
cleocapsid (Hirsch et al., 1990; Bartenschlager et al.,
1990; Bartenschlager and Schaller, 1992; Pollack and
Ganem, 1993, 1994; Fallows and Goff, 1995). Initially
three nucleotides are synthesized utilizing the bulge re-
gion of  as the template and a tyrosine residue in the
amino-terminal domain of the polymerase molecule as a
primer (Gerlich and Robinson, 1980; Wang and Seeger,
1992, 1993; Zoulim and Seeger, 1994; Weber et al., 1994;
Tavis et al., 1994; Lanford et al., 1995, 1997; Nassal and
Rieger, 1996; Jiang and Loeb, 1997). The polymerase
molecule with the covalently attached trinucleotide se-
quence is subsequently translocated from  to the DR1
sequence at the 3-end of the pregenomic RNA (Seeger
and Maragos, 1991; Tavis et al., 1994; Tavis and Ganem,
1995; Loeb and Tian, 1995; Nassal and Rieger, 1996). The
mechanism controlling this translocation step is poorly
understood. Although the three nucleotides encoded by
the bulge region of  are complementary to the 5-end of
the DR1 sequence, this complementarity is not sufficient
to uniquely specify this translocation event (Tavis et al.,
1994; Tavis and Ganem, 1995; Loeb and Tian, 1995;
Nassal and Rieger, 1996). It has been speculated that
additional sequences within the pregenomic RNA may
help to position the HBV polymerase molecule in prox-
imity to the DR1 sequence at the 3-end of pregenomic
RNA so as to aid in the translocation of the primer of
minus-strand synthesis (Wang and Seeger, 1993; Tavis
and Ganem, 1995; Loeb and Tian, 1995; Nassal and
Rieger, 1996).
In an attempt to investigate this possibility, a series of
mutations were introduced into the region of the HBV
genome immediately upstream of the DR1 sequence
located at the 3-end of the HBV DNA (4.1 kb) construct
(Fig. 1). Pregenomic RNA transcribed from these con-
structs contained the nucleotide substitutions only at the
3-end of the transcripts. The nucleotide substitutions
also did not alter the sequence of the X-gene polypeptide
encoded by this region of the HBV genome (Fig. 1). The
level of the HBV RNAs transcribed from the mutant HBV
DNA (4.1 kb) constructs in HepG2 cells was very similar
to the wild-type construct (Fig. 2A). This indicated that the
mutations introduced into the HBV genome did not alter
viral transcription. Similarly, the level of viral replication
observed with the HBV DNA (4.1 kb) M1, M2, M3,
M4, M5, and M8 mutant constructs in HepG2 cells
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was very similar to the level of replication observed with
the wild-type construct (Figs. 2B and 2C). In contrast, the
level of replication per 3.5-kb viral transcript with the HBV
DNA (4.1 kb) M6 and M7 mutant constructs in HepG2
cells was reduced approximately fivefold relative to the
level of replication observed with the wild-type construct
(Figs. 2B and 2C). This indicates that the sequence
located between nucleotide coordinates 1769 and 1791
is necessary for efficient HBV replication.
The mutant HBV DNA (4.1 kb) constructs were also
examined in mouse NIH 3T3 fibroblasts where replica-
tion was dependent on the ectopic expression of the
nuclear hormone receptors, RXR and PPAR (Fig. 3)
(Tang and McLachlan, 2001). As observed in HepG2
cells, HBV transcription was not affected by any of the
mutations located upstream of the DR1 sequence at the
3-end of the pregenomic RNA (Fig. 3A). The level of viral
replication observed with the HBV DNA (4.1 kb) M1,
M2, M3, M4, M5, and M8 mutant constructs in
mouse fibroblasts was very similar to the level of repli-
cation observed with the wild-type construct (Figs. 3B
and 3C). As described for HepG2 cells, the level of
replication per 3.5-kb viral transcript with the HBV DNA
(4.1 kb) M6 and M7 mutant constructs in mouse fibro-
blasts was reduced fourfold relative to the level of rep-
lication observed with the wild-type construct (Figs. 3B
FIG. 1. Structure and sequence of the HBV constructs supporting viral transcription and replication in the human HepG2 hepatoma cell line and
mouse NIH 3T3 fibroblasts. (A) Structure of the HBV DNA (4.1 kb) construct used in transient transfection analysis. The 4.1-kb greater-than-genome
length HBV DNA sequence in this construct spans coordinates 1072–3182/1–1990 of the HBV genome (subtype ayw). The locations of the HBV 3.5-,
2.4-, 2.1-, and 0.7-kb transcripts are indicated. EnhI/Xp, enhancer I/X-gene promoter region; Cp, nucleocapsid or core promoter; pA, polyadenylation
site; PS1p, presurface antigen promoter; Sp, major surface antigen promoter; X, X gene; S, surface antigen gene; C, core gene; P, polymerase gene;
ORF, open reading frame. (B) Sequence of the HBV phi (), DR1, and epsilon () region of the viral genome. The M1 to M8 mutations spanning the
 sequence are indicated above the HBV nucleotide sequence. These mutations were only introduced into the 3-end of the HBV DNA (4.1 kb)
construct. The sequence of the X gene encoded polypeptide is not changed by the M1 to M8 mutations in the X gene open reading frame (X-ORF).
The location of the precore (PC) and pregenomic or core (C) RNA initiation sites are indicated.
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and 3C). These observations agree with the results using
HepG2 cells and further support the suggestion that the
sequence located between nucleotide coordinates 1769
and 1791 is necessary for efficient HBV replication.
To demonstrate that the mutations introduced at the
3-end of the pregenomic RNA did not affect transcription
initiation from the nucleocapsid promoter, the levels of
the precore and pregenomic RNAs were examined (Fig.
4). The mutations do not appear to modulate the abun-
FIG. 3. Effect of mutations in the  sequence on HBV transcription and
replication in mouse NIH 3T3 fibroblasts. Cells were transiently trans-
fected with the wild-type HBV DNA (4.1 kb) construct (lane 1) and the
mutant HBV DNA (4.1 kb) constructs, M1 (lane 2), M2 (lane 3), M3
(lane 4), M4 (lane 5), M5 (lane 6), M6 (lane 7), M7 (lane 8), and M8
(lane 9). The RXR-PPAR expression vectors were included in each
transfection to mediate the expression of the 3.5-kb HBV RNA and viral
replication (Tang andMcLachlan, 2001). All-trans retinoic acid and clofibric
acid at 1 M and 1 mM, respectively, were used to activate the nuclear
hormone receptors, RXR and PPAR. (A) RNA (Northern) filter hybridiza-
tion analysis of HBV transcripts. The glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) transcript was used as an internal control for RNA
loading per lane. (B) DNA (Southern) filter hybridization analysis of HBV
replication intermediates. HBV RC DNA, HBV relaxed circular DNA; HBV
SS DNA, HBV single-stranded DNA. (C) Quantitative analysis of the 3.5-kb
HBV RNA and HBV DNA replication intermediates. The levels of the 3.5-kb
HBV RNA and HBV DNA replication intermediates are reported relative to
the HBV DNA (4.1 kb) construct (lane 1) which are designated as having a
relative activity of 1.0. The mean RNA and DNA levels plus standard
deviations from two independent analyses are shown.
FIG. 2. Effect of mutations in the  sequence on HBV transcription
and replication in HepG2 cells. Cells were transiently transfected with
the wild-type HBV DNA (4.1 kb) construct (lane 1) and the mutant HBV
DNA (4.1 kb) constructs, M1 (lane 2), M2 (lane 3), M3 (lane 4), M4
(lane 5), M5 (lane 6), M6 (lane 7), M7 (lane 8), and M8 (lane 9). (A)
RNA (Northern) filter hybridization analysis of HBV transcripts. The
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript was
used as an internal control for RNA loading per lane. (B) DNA (South-
ern) filter hybridization analysis of HBV replication intermediates. HBV
RC DNA, HBV relaxed circular DNA; HBV SS DNA, HBV single-stranded
DNA. (C) Quantitative analysis of the 3.5-kb HBV RNA and HBV DNA
replication intermediates. The levels of the 3.5-kb HBV RNA and HBV
DNA replication intermediates are reported relative to the HBV DNA (4.1
kb) construct (lane 1) which are designated as having a relative activity
of 1.0. The mean RNA and DNA levels plus standard deviations from
two independent analyses are shown.
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dance of the precore and pregenomic transcripts (Fig.
4B) and therefore alterations in the levels of these tran-
scripts cannot account for the effects of the M6 and
M7 mutations on viral replication.
The pregenomic RNA sequence required for efficient
HBV replication is complementary to 
Examination of the pregenomic RNA sequence re-
quired for efficient HBV replication revealed that 19 nu-
cleotides in this region spanning coordinates 1775 to
1793 and designated phi () was complementary to the
5-half of the sequence of the stem-loop structure of 
(Figs. 1B, 5B, and 6B).  is located 32 nucleotides up-
stream of the DR1 sequence (Figs. 1B and 5). The
complementarity between  and  suggests possible
roles for the  sequence in regulating HBV replication.
The absence of the  sequence at the 5-end of the
pregenomic RNA suggests that the initial formation of the
 stem-loop structure in this region of the transcript is
probably not influenced by the presence of the  se-
quence at the 3-end of the pregenomic RNA (Fig. 5A).
The presence of the  and  sequences in close prox-
imity at the 3-end of the pregenomic RNA could result in
duplex formation between these sequence elements and
the inhibition of  formation at the 3-end of the pre-
genomic RNA. This possibility might explain the absence
of minus-strand HBV DNA initiation from the  sequence
at the 3-end of the pregenomic RNA (Junker-Niepmann
et al., 1990; Knaus and Nassal, 1993). However, the
absence of minus-strand HBV DNA initiation from the 
sequence at the 3-end of the pregenomic RNA may be
independent of the  sequence. The M6 and M7
mutations do not promote the synthesis of HBV minus-
strand DNA from the bulge region of the  sequence at
the 3-end of the pregenomic RNA as might be predicted
by this simple model (H. Tang and A. McLachlan, unpub-
lished data).
The complementarity between  and  may influence
HBV replication efficiency directly by increasing the rate
of translocation of the polymerase from  at the 5-end of
the pregenomic RNA to the DR1 sequence at the 3 end
of the pregenomic RNA (Figs. 5 and 6). The 5-half of 
may base-pair with  that is adjacent to the DR1 se-
quence at the 3-end of the pregenomic RNA (Figs. 5B
and 6B). This arrangement would bring the site where
the three nucleotides encoded by the bulge of  are
covalently attached to the HBV polymerase in close prox-
imity to the DR1 sequence where minus-strand DNA
elongation occurs. The proximity of the polymerase to
the DR1 sequence at the 3-end of the pregenomic RNA
may favor its translocation to DR1 and the subsequent
synthesis of the complete HBV minus-strand DNA.
Based on the structure of  and the suggested nature
of the / stem, a speculative model for the initial steps
in minus-strand synthesis can be proposed (Figs. 5 and
6). The  stem-loop structure forms at the 5-end of the
pregenomic RNA (Figs. 5A and 6A). Polymerase binds
this structure and covalently attaches three nucleotides
to a tyrosine residue in its amino-terminal domain using
the bulge region as template. The synthesis of the three
nucleotides alters the conformation of the polymerase so
the loop in  can become dramatically enlarged (Figs. 5B
and 6B). This might occur either by sliding the pre-
genomic sequence through the polymerase or by releas-
ing the 3-half of the  sequence and subsequently an-
nealing with the  sequence. Regardless of the mecha-
nism, the 5-half of  would ultimately be base-paired
with the  sequence, generating a new stem-loop struc-
ture (Figs. 5B and 6B). In this structure, the lower stem is
shorter than that observed in  and the bulge region is
displaced by one nucleotide (Fig. 6B). This new structure
presumably favors the translocation of the polymerase
with the covalently attached nucleotides to the DR1 se-
FIG. 4. Effect of mutations in the  sequence on HBV precore and
pregenomic RNA synthesis in HepG2 cells. Cells were transiently
transfected with the wild-type HBV DNA (4.1 kb) construct (lane 1) and
the mutant HBV DNA (4.1 kb) constructs, M1 (lane 2), M2 (lane 3),
M3 (lane 4), M4 (lane 5), M5 (lane 6), M6 (lane 7), M7 (lane 8),
and M8 (lane 9). (A) Primer extension analysis of the 3.5-kb HBV RNA
transcribed from the wild-type and mutant HBV DNA (4.1 kb) constructs.
(B) Quantitative analysis of the precore and pregenomic (or core) 3.5-kb
HBV RNA. The levels of the precore and core RNA are reported relative
to the level of the core RNA transcribed from the HBV DNA (4.1 kb)
construct (lane 1) which is designated as having a relative activity of
1.0. The ratio of the precore to core transcripts is also indicated.
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quence at the 3-end of the pregenomic RNA as it has
now been brought into close proximity with the polymer-
ase by the reorganization of the pregenomic RNA struc-
ture.
Examination of the WHV sequence indicates that the
complementarity between  and  sequences is con-
served in this hepadnavirus (Fig. 7). The WHV pre-
genomic RNA can form essentially identical secondary
structures to those proposed for HBV. In the case of
DHBV, similar but not identical structures can be formed
(Fig. 8). The bulge in the  sequence is still displaced by
a single nucleotide when it associates with the  se-
quence (Fig. 8B). However, in the proposed structure the
bulge is reduced from six nucleotides to four and the
lower stem is shorter than proposed for the mammalian
hepadnaviruses. This probably reflects the significantly
reduced distance between the DR1 and DR2 sequences
in DHBV compared with the mammalian hepadnavi-
ruses. In addition, there is a second bulge in the DHBV
/ structure directly opposite the original bulge se-
quence present in the  structure (Fig. 8B). This obser-
vation suggests that the lower stem structure may not be
required for polymerase translocation in the case of
DHBV. Regardless of these differences, it is apparent
that these hepadnaviruses each have a sequence ele-
ment upstream of DR1 that is complementary to . The
evolutionary conservation of these sequence elements
suggests they are involved in generating pregenomic
RNA secondary structures that enhance the efficiency of
polymerase translocation from  at the 5-end of the
pregenomic RNA to the DR1 sequence at the 3-end of
the pregenomic RNA. In this manner,  may increase the
efficiency of hepadnavirus replication.
In the future, it will be necessary to establish if the 
and  sequences form the proposed stem-loop struc-
tures (Figs. 5–8) that may enhance the efficiency of the
translocation of the polymerase with the covalently at-
tached nucleotides from  to the DR1 sequence at the
FIG. 5. Putative alternative structures of the HBV pregenomic RNA at distinct stages of minus-strand synthesis. (A) Secondary structure of HBV
pregenomic RNA with the  stem-loop structure at both the 5- and the 3-ends of the transcript. The HBV polymerase is located at the 5-end 
sequence and has the first three nucleotides of the minus-strand (5-GAA-3) located at their site of synthesis in the bulge of . (B) Secondary structure
of the HBV pregenomic RNA with the 5-half of the  sequence base-paired with the  sequence at the 3-end of the transcript. As a consequence
of the reorganization of the structure of the pregenomic RNA, the HBV polymerase has been translocated to DR1 at the 3-end of the transcript and
the first three nucleotides of the minus-strand (5-GAA-3) are located at the 5-end of this DR1 sequence. The pregenomic RNA is not drawn to scale.
DR1, direct repeat sequence 1; , epsilon; DR2, direct repeat sequence 2; , phi.
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3-end of the pregenomic RNA. This might be addressed
by introducing compensating mutations into the 5-half of
the  sequence to base-pair with the mutations in the 
sequence that have been shown to inhibit viral replica-
tion. Restoring a wild-type level of HBV replication would
indicate that  and  sequences functionally interact
during viral DNA synthesis. However in practice this
approach is likely to be very difficult as mutations in the
5-half of the  sequence will also disrupt the base-
pairing with the 3-half of the  sequence. This will alter
the stem-loop structure of . Consequently these muta-
tions are likely to prevent polymerase binding and the
initial priming step in viral replication that occurs at the
bulge region of . This would prevent the functional
interaction of  and  sequences from being examined.
Alternatively, secondary structure analysis of in vitro syn-
thesized viral transcripts using ribonuclease digestions
might indicate if the  and  sequences can base-pair to
form the proposed stem-loop structure. This type of ad-
ditional analysis will be required to support the putative
FIG. 6. HBV pregenomic RNA secondary structures that may be involved in polymerase transfer from  to the DR1 sequence during minus-strand
DNA synthesis. (A) Structure of the HBV  stem-loop sequence. The location of the HBV polymerase (Pol) with the three covalently attached
nucleotides is indicated. (B) Structure of the HBV / stem-bulge sequence. The location of the HBV polymerase with the three covalently attached
nucleotides after translocation from  to DR1 is indicated. The locations of the M6 to M8 mutations are also indicated. The pregenomic RNA
sequence is derived from the HBVayw genome (Galibert et al., 1979).
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model of minus-strand synthesis suggested by these
initial mutagenesis studies.
MATERIALS AND METHODS
Plasmid constructions
The steps in the cloning of the plasmid constructs
used in the transfection experiments were performed by
standard techniques (Sambrook et al., 1989). HBV DNA
sequences in these constructions were derived from the
plasmid pCP10, which contains two copies of the HBV
genome (subtype ayw) cloned into the EcoRI site of
pBR322 (Dubois et al., 1980). The HBV DNA (4.1 kb)
construct that contains 1.3 copies of the HBV genome
includes the viral sequence from nucleotide coordinates
1072 to 3182 plus 1 to 1990. This plasmid was con-
structed by cloning the NsiI/BglII HBV DNA fragment
(nucleotide coordinates 1072 to 1990) into pUC13, gen-
erating pHBV(1072–1990). Subsequently, a complete
copy of the 3.2-kb viral genome linearized at the NcoI site
(nucleotide coordinates 1375 to 3182 plus 1 to 1374) was
cloned into the unique NcoI site (HBV nucleotide coor-
FIG. 7. WHV pregenomic RNA secondary structures that may be involved in polymerase transfer from  to the DR1 sequence during minus-strand
DNA synthesis. (A) Structure of the WHV  stem-loop sequence. The location of the WHV polymerase (Pol) with the three covalently attached
nucleotides is indicated. (B) Structure of the WHV / stem-bulge sequence. The location of the WHV polymerase with the three covalently attached
nucleotides after translocation from  to DR1 is indicated. The pregenomic RNA sequence is derived from the WHV2 genome (Kodama et al., 1985).
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dinate 1374) of pHBV(1072–1990), generating the HBV
DNA (4.1 kb) construct (Fig. 1A).
The plasmids, M1, M2, M3, M4, M5, M6,
M7, and M8, were derived by introducing the nucle-
otide substitutions indicated in Fig. 1 into the sequence
between coordinates 1747 and 1798 located immediately
upstream of the 3 DR1 element in the HBV DNA (4.1 kb)
constructs. The Chameleon double-stranded, site-di-
rected mutagenesis kit (Stratagene Cloning Systems, La
Jolla, CA) was used according to the manufacturer’s
instructions. The nucleotide substitutions introduced into
the nucleocapsid promoter constructs were verified by
dideoxynucleotide sequencing (Sanger et al., 1977). Only
the sequences upstream of the 3 DR1 sequence in
these terminally redundant HBV constructs were mu-
tated for this analysis.
The pRS-hRXR and pCMVPPAR-G vectors express
RXR and PPAR-G polypeptides from the human RXR
and mouse PPAR-G cDNAs, respectively, using the
Rous sarcoma virus LTR (pRS) and the cytomegalovirus
immediate-early promoter (pCMV) (Mangelsdorf et al.,
1990; Muerhoff et al., 1992). The PPAR-G polypeptide
contains a mutation in the PPAR cDNA changing Glu282
to Gly that may decrease the affinity of the receptor for
FIG. 8. DHBV pregenomic RNA secondary structures that may be involved in polymerase transfer from  to the DR1 sequence during minus-strand
DNA synthesis. (A) Structure of the DHBV  stem-loop sequence. The location of the DHBV polymerase (Pol) with the three covalently attached
nucleotides is indicated. (B) Structure of the DHBV / stem-bulge sequence. The location of the DHBV polymerase with the three covalently attached
nucleotides after translocation from  to DR1 is indicated. The pregenomic RNA sequence is derived from the DHBV16 genome (Mandart et al., 1984).
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the endogenous ligand. Consequently, this mutation in-
creases the peroxisome proliferator-dependent (i.e., clo-
fibric acid-dependent) activation of transcription from a
peroxisome proliferator response element (PPRE) con-
taining promoter (Muerhoff et al., 1992) and was used in
this study to demonstrate the peroxisome proliferator-
dependent transcriptional transactivation of the nucleo-
capsid promoter.
Cells and transfections
The human hepatoma cell line HepG2 and the mouse
NIH 3T3 fibroblast cell line were grown in RPMI-1640
medium and 10% fetal bovine serum at 37°C in 5%
CO2/air. Transfections for viral RNA and DNA analysis
were performed as previously described (McLachlan et
al., 1987) using 10-cm plates, containing approximately
1  106 cells. DNA and RNA isolation was performed 3
days posttransfection (Tang and McLachlan, 2001). The
transfected DNA mixture was composed of 10 g of HBV
DNA (4.1 kb) plus 1.5 g of the liver-enriched transcrip-
tion factor expression vectors, pRS-hRXR and pCMVP-
PAR-G, as required (Raney et al., 1997; Tang and
McLachlan, 2001). All-trans retinoic acid and clofibric
acid at 1 M and 1 mM, respectively, were used to
activate the nuclear hormone receptors, RXR and
PPAR.
Characterization of HBV transcripts and viral
replication intermediates
Transfected cells from a single plate were divided
equally and used for the preparation of total cellular RNA
and viral DNA replication intermediates as described
previously (Summers et al., 1991) with minor modifica-
tions (Tang and McLachlan, 2001). For RNA isolation
(Chomczynski and Sacchi, 1987) the cells were lysed in
1.8 ml of 25 mM sodium citrate, pH 7.0, 4 M guanidinium
isothiocyanate, 0.5% (v/v) sarcosyl, 0.1 M 2-mercapto-
ethanol. After addition of 0.18 ml of 2 M sodium acetate,
pH 4.0, the lysate was extracted with 1.8 ml of water-
saturated phenol plus 0.36 ml of chloroform-isoamyl al-
cohol (49:1). After centrifugation for 30 min at 3000 rpm in
a Sorval RT6000, the aqueous layer was precipitated
with 1.8 ml of isopropanol. The precipitate was resus-
pended in 0.3 ml of 25 mM sodium citrate, pH 7.0, 4 M
guanidinium isothiocyanate, 0.5% (v/v) sarcosyl, 0.1 M
2-mercaptoethanol and precipitated with 0.6 ml of etha-
nol. After centrifugation for 20 min at 14,000 rpm in an
Eppendorf 5417C microcentrifuge, the precipitate was
resuspended in 0.3 ml of 10 mM Tris hydrochloride, pH
8.0, 5 mM EDTA, 0.1% (w/v) sodium lauryl sulfate and
precipitated with 45 l of 2 M sodium acetate plus 0.7 ml
of ethanol.
For the isolation of viral DNA replication intermediates,
the cells were lysed in 0.4 ml of 100 mM Tris hydrochlo-
ride, pH 8.0, 0.2% (v/v) NP-40. The lysate was centrifuged
for 1 min at 14,000 rpm in an Eppendorf 5417C micro-
centrifuge to pellet the nuclei. The supernatant was ad-
justed to 6.75 mM magnesium acetate plus 200 g/ml
DNase I and incubated for 1 h at 37°C to remove the
transfected plasmid DNA. The supernatant was read-
justed to 100 mM NaCl, 10 mM EDTA, 0.8% (w/v) sodium
lauryl sulfate, 1.6 mg/ml pronase and incubated for an
additional 1 h at 37°C. The supernatant was extracted
twice with phenol, precipitated with 2 vol of ethanol, and
resuspended in 100 l of 10 mM Tris–hydrochloride, pH
8.0, 1 mM EDTA.
RNA (Northern) and DNA (Southern) filter hybridization
analyses were performed using 10 g of total cellular
RNA and 30 l of viral DNA replication intermediates,
respectively, as described (Sambrook et al., 1989). Tran-
scription initiation sites for the HBV 3.5-kb transcripts
were examined by primer extension analysis using 4
units of avian myeloblastosis virus reverse transcriptase
(Roche), 7 ng 32P-labeled HBV oligonucleotide probe,
GGAAAGAAGTCAGAAGGCAAAAACGAGAGTAACTCC
(HBV coordinates 1976 to 1941), and 10 g of total cel-
lular RNA as described by the manufacturer. Filter hy-
bridization and primer extension analyses were quanti-
tated by phosphorimaging using a Packard Cyclone Stor-
age Phosphor System.
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